pentamidine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinaldi, F | 1 |
| Seguella, L | 1 |
| Gigli, S | 1 |
| Hanieh, PN | 1 |
| Del Favero, E | 1 |
| Cantù, L | 1 |
| Pesce, M | 1 |
| Sarnelli, G | 1 |
| Marianecci, C | 1 |
| Esposito, G | 1 |
| Carafa, M | 1 |
1 other study available for pentamidine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice.
Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Brain; Chitosan | 2019 |